Shopping Cart
- Remove All
Your shopping cart is currently empty
TRX-518 is a humanized agonist antibody targeting the glucocorticoid-induced tumor necrosis factor receptor (GITR). It specifically targets GITR⁺ regulatory T cells (Tregs) and CD45RA⁻Foxp3⁺ effector Tregs (eTregs) within regulatory T cells, effectively reducing the number of Tregs in circulation and within tumors.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | Inquiry | Backorder | |
| 5 mg | Inquiry | Backorder |
| Description | TRX-518 is a humanized agonist antibody targeting the glucocorticoid-induced tumor necrosis factor receptor (GITR). It specifically targets GITR⁺ regulatory T cells (Tregs) and CD45RA⁻Foxp3⁺ effector Tregs (eTregs) within regulatory T cells, effectively reducing the number of Tregs in circulation and within tumors. |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.